<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-XPKS8GCE</identifier><date>2005</date><creator>Kerec, Mojca</creator><relation>documents/znanstveni_clanki/farmacevtski_vestnik/html/urn_nbn_si_doc-xpks8gce.html</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/pdf/urn_nbn_si_doc-xpks8gce.pdf</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/txt/urn_nbn_si_doc-xpks8gce.txt</relation><format format_type="issue">1</format><format format_type="volume">56</format><format format_type="main">8 strani</format><format format_type="type">article</format><format format_type="extent">str. 3-10</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">1722737</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-XPKS8GCE</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">citokromi</subject><subject language_type_id="slv">farmakodinamika</subject><subject language_type_id="slv">farmakokientika</subject><subject language_type_id="slv">interakcije</subject><subject language_type_id="slv">zaviralci kalcijevih kanalčkov</subject><title>Interakcije zdravil: zaviralci kalcijevih kanalčkov</title></Record>